These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11584358)
1. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358 [TBL] [Abstract][Full Text] [Related]
2. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612 [TBL] [Abstract][Full Text] [Related]
3. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054 [TBL] [Abstract][Full Text] [Related]
4. Different expression of cyclooxygenase-2 in biliary epithelia of bile duct cancer with or without pancreaticobiliary maljunction. Watanabe O; Yoshimatsu K; Shiozawa S; Tsuchiya A; Oshibe N; Aiba M; Ogawa K Anticancer Res; 2004; 24(2B):671-4. PubMed ID: 15161010 [TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase 2 in human malignant melanoma. Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178 [TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression in the gallbladder of patients with anomalous arrangement of the pancreaticobiliary duct. Fumino S; Tokiwa K; Ono S; Iwai N J Pediatr Surg; 2003 Apr; 38(4):585-9. PubMed ID: 12677571 [TBL] [Abstract][Full Text] [Related]
7. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines. Waskewich C; Blumenthal RD; Li H; Stein R; Goldenberg DM; Burton J Cancer Res; 2002 Apr; 62(7):2029-33. PubMed ID: 11929821 [TBL] [Abstract][Full Text] [Related]
8. The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells. Grossman EM; Longo WE; Panesar N; Mazuski JE; Kaminski DL Carcinogenesis; 2000 Jul; 21(7):1403-9. PubMed ID: 10874020 [TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of expression of cyclooxygenase-2 gene in breast cancer]. Guo GL; Yao ZX; Wu J Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1661-4. PubMed ID: 14642098 [TBL] [Abstract][Full Text] [Related]
10. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas]. Zhan J; Tang XD Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas. Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191 [TBL] [Abstract][Full Text] [Related]
14. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687 [TBL] [Abstract][Full Text] [Related]
15. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888 [TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
19. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220 [TBL] [Abstract][Full Text] [Related]
20. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]